Markets:

Overview

News

Currencies

International

Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

35.46 +1.58 (+4.66%)

Streaming Delayed Price Updated: 1:07 PM EST, Dec 3, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

28 29 Next >

Why Weight-Loss Developer Stocks Tumbled on Tuesday ↗

May 13, 2025

Via The Motley Fool

Topics Government

2 Monster Stocks in the Making to Buy Now and Hold for 10 Years ↗

May 13, 2025

Via The Motley Fool

3 Monster Stocks in the Making ↗

May 11, 2025

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 09, 2025

Via Benzinga

Down Nearly 20%: Should You Buy the Dip on Eli Lilly? ↗

May 08, 2025

Via The Motley Fool

Topics Earnings Government World Trade

Earnings Scheduled For April 23, 2025 ↗

April 23, 2025

Via Benzinga

Earnings Preview For Viking Therapeutics ↗

April 22, 2025

Via Benzinga

How Is The Market Feeling About Viking Therapeutics? ↗

April 21, 2025

Via Benzinga

Why Viking Therapeutics Stock Surged Nearly 20% Higher in April ↗

May 06, 2025

Via The Motley Fool

Why Viking Therapeutics Stock Was Victorious This Week ↗

May 02, 2025

Via The Motley Fool

Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday ↗

May 02, 2025

GLP-1 drug prices are falling. That's good news for patients, but perhaps not such good news for pharmaceutical stock investors.

Via The Motley Fool

Topics World Trade

Is Novo Nordisk Stock a Buy? ↗

May 02, 2025

Via The Motley Fool

Where Will Viking Therapeutics Be in 3 Years? ↗

May 02, 2025

Viking's leading drug candidate could be a blockbuster in the weight loss market, which experts believe could grow to $150 billion over the coming years.

Via The Motley Fool

Topics Bankruptcy

1 Beaten-Down Stock to Buy and Hold for 10 Years ↗

May 01, 2025

Via The Motley Fool

Topics Economy

Will Pfizer Will Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback? ↗

April 30, 2025

Via The Motley Fool

Prediction: Pfizer's Loss May Be Viking Therapeutics' Gain ↗

April 30, 2025

Via The Motley Fool

Why Viking Therapeutics Stock Popped Again Today ↗

April 29, 2025

Cantor Fitzgerald thinks the GLP-1 diet drug VK2735 will be a "multi-blockbuster" for Viking stock.

Via The Motley Fool

Why Viking Therapeutics Stock Popped Today ↗

April 28, 2025

2025 is the year we learn whether Viking Therapeutics stock will be a winner.

Via The Motley Fool

Viking Therapeutics Stock May Struggle After As-Expected Report

April 25, 2025

Viking Therapeutics stock is trying to push higher as investors attempt to sort out a report that delivered no real news that investors hadn’t already heard.

Via MarketBeat

Viking Therapeutics Stock Dips After Q1 EPS Miss: Details ↗

April 23, 2025

Viking Therapeutics releases its first-quarter results after Wednesday's closing bell. Here's a look at the details from the report.

Via Benzinga

A Look At Viking Therapeutics VKTX ↗

April 21, 2025

While we wait for the earnings report to be posted along with the forward guidance predictions, the chart looks interesting.

Via Talk Markets

Topics Stocks / Equities

Did Eli Lilly Just Say Checkmate to Novo Nordisk? ↗

April 21, 2025

Via The Motley Fool

Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide ↗

April 17, 2025

Eli Lilly has a plan to dominate the GLP-1 weight loss drug market -- and it's succeeding.

Via The Motley Fool

2 Stocks Down by 25% or More This Year to Buy and Hold ↗

April 17, 2025

Via The Motley Fool

Topics Government

Eli Lilly Stock Rockets On Weight-Loss Pill Progress ↗

April 17, 2025

Eli Lilly's pill-form weight loss drug cansdidate cleared one of several Phase III hurdles.

Via Investor's Business Daily

Topics Government

Viking Therapeutics Stock Pops But Struggles to Hold Gains

April 16, 2025

VKTX stock shot higher after announcing a phase 3 trial for its GLP-1 drug candidate; but investors are concerned about a lack of support in Washington

Via MarketBeat

Will Pfizer Approach Viking Therapeutics With A Buyout Proposa ↗

April 15, 2025

Investors are running into Viking Therapeutics this week after an incident of drug-induced liver injury pushed Pfizer into terminating the development of its weight-loss pill.

Via Talk Markets

Topics Stocks / Equities

Down 71%, Should You Buy the Dip on Viking Therapeutics Stock? ↗

April 15, 2025

Via The Motley Fool

Wall Street Sees Pfizer's Weight-Loss Pill Exit As A Win For 2 Smaller Biotech Firms: Retail Turns Bullish ↗

April 15, 2025

Investors are now considering the possibility of Pfizer acquiring either of these companies as it looks for external candidates.

Via Stocktwits

Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today ↗

April 14, 2025

Pfizer bows, but is not entirely out of the GLP-1 race.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

28 29 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.